A comparative pharmacokinetic study of EVRA and CILEST in healthy female volunteers
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Ethinylestradiol/norelgestromin (Primary) ; Ethinylestradiol/norgestimate (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Janssen Research & Development
- 01 May 2007 Status change
- 28 Oct 2006 New trial record.